Mycenax Biotech Inc
TPEX:4726
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mycenax Biotech Inc
TPEX:4726
|
TW |
|
E
|
Empresas Copec SA
SGO:COPEC
|
CL |
|
T
|
Terracom Ltd
F:2GF
|
AU |
|
A
|
adesso SE
XHAN:ADN1
|
DE |
|
Emerald Holding Inc
NYSE:EEX
|
US |
|
P
|
Pernod Ricard SA
XHAN:PER
|
FR |
|
D
|
Deutsche Telekom AG
XHAN:DTE
|
DE |
|
Ibex Ltd
NASDAQ:IBEX
|
US |
|
S
|
SAP SE
XHAN:SAP
|
DE |
|
L
|
Linedata Services SA
LSE:0F2S
|
FR |
|
B
|
BAWAG Group AG
OTC:BWAGF
|
AT |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XHAN:MOH
|
FR |
|
L
|
Lixil Corp
SWB:TJS
|
JP |
|
F
|
Fiserv Inc
XHAN:FIV
|
US |
|
G
|
Gen Digital Inc
XHAN:SYM
|
US |
|
B
|
Broadcom Inc
XHAN:1YD
|
US |
|
Nordic LEVEL Group AB
F:9T2
|
SE |
|
I
|
Iberpapel Gestion SA
LSE:0ERM
|
ES |
|
Cantargia AB
STO:CANTA
|
SE |
Bankruptcy Probability
Mycenax Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mycenax Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
M
|
Mycenax Biotech Inc
TPEX:4726
|
5B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mycenax Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mycenax Biotech Inc has total debt of 947.3m TWD. This includes both short-term (450m TWD) and long-term (497.3m TWD) debt.
You can find a full breakdown on its Balance Sheet.
